<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Ventricular tachycardia in the absence of apparent structural heart disease</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Ventricular tachycardia in the absence of apparent structural heart disease</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Ventricular tachycardia in the absence of apparent structural heart disease</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David J Callans, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">N A Mark Estes, III, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Todd F Dardas, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 06, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The evaluation and management of ventricular tachyarrhythmias are uniquely challenging due to the unpredictable and potentially lethal nature of the events. When evaluating patients with ventricular tachycardia (VT) and ventricular fibrillation (VF), several initial distinctions should be made. These include:</p><p class="bulletIndent1"><span class="glyph">●</span>Arrhythmia duration – Sustained or nonsustained</p><p class="bulletIndent1"><span class="glyph">●</span>Arrhythmia morphology – Monomorphic VT, polymorphic VT, or VF</p><p class="bulletIndent1"><span class="glyph">●</span>Associated symptoms – Ranging from none to hemodynamic collapse and sudden cardiac arrest</p><p class="bulletIndent1"><span class="glyph">●</span>Associated cardiac disease</p><p></p><p>Malignant arrhythmias usually occur in the presence of significant structural heart disease (eg, coronary heart disease with prior myocardial infarction, dilated cardiomyopathy, or hypertrophic cardiomyopathy). In this setting, ventricular arrhythmias carry a high risk of sudden cardiac death (SCD).</p><p>Less commonly, VT and VF occur in hearts that appear normal. In many such cases, however, the heart is in fact not normal, but rather has less visible abnormalities including derangements of cardiac ion channels or structural proteins. In these patients, ventricular arrhythmias also carry a high risk of SCD. Thus, a significant majority of patients with VT or VF have some form of underlying cardiac disease, are at increased risk for SCD, and require a thorough cardiac evaluation to exclude structural abnormalities and nonstructural disorders. (See  <a class="medical medical_review" href="/d/html/970.html" rel="external">"Cardiac evaluation of the survivor of sudden cardiac arrest"</a>.)</p><p>There are, however, some VT syndromes which occur in normal hearts that have a more benign prognosis [<a href="#rid1">1,2</a>]. These arrhythmias are sometimes referred to as idiopathic VT. Terminology and classifications vary, but three commonly cited syndromes are:</p><p class="bulletIndent1"><span class="glyph">●</span>Repetitive monomorphic VT, which is also referred to as right ventricular outflow tract (RVOT) VT. This arrhythmia is due to triggered activity and is sensitive to <a class="drug drug_general" data-topicid="9359" href="/d/drug information/9359.html" rel="external">adenosine</a>. An arrhythmia with similar characteristics that originates from the left ventricular outflow tract has also been described.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Paroxysmal sustained VT, which is sometimes considered a variant of RVOT VT.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Idiopathic left ventricular tachycardia, which originates from the posterior septum, is due to reentry, and is sensitive to <a class="drug drug_general" data-topicid="10043" href="/d/drug information/10043.html" rel="external">verapamil</a>.</p><p></p><p>These arrhythmias have substrate and mechanisms that are different from the malignant arrhythmias that occur in both abnormal and apparently normal hearts. Thus, they should be considered distinct syndromes rather than well-tolerated forms of other ventricular arrhythmia syndromes. The diagnosis, characterization, and management of these monomorphic VTs will be reviewed here.</p><p>Sustained and nonsustained ventricular arrhythmias in patients with heart disease, and malignant ventricular arrhythmias in the absence of apparent structural heart disease are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/1040.html" rel="external">"Sustained monomorphic ventricular tachycardia in patients with structural heart disease: Treatment and prognosis"</a> and  <a class="medical medical_review" href="/d/html/1019.html" rel="external">"Approach to sudden cardiac arrest in the absence of apparent structural heart disease"</a> and  <a class="medical medical_review" href="/d/html/933.html" rel="external">"Nonsustained VT in the absence of apparent structural heart disease"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">IDIOPATHIC VENTRICULAR ARRHYTHMIAS</span><span class="headingEndMark"> — </span>Although the term idiopathic VT is widely used for the monomorphic VT syndromes described here, use of "idiopathic" can be misleading. Historically, both VT and VF that occur in the absence of apparent heart disease have been referred to as idiopathic. However, with continual improvements in both the understanding of arrhythmia mechanisms and diagnostic methods, an increasing percentage of patients are now given a diagnosis (eg, Brugada syndrome, arrhythmogenic right ventricular cardiomyopathy [ARVC], and catecholaminergic polymorphic VT). In contrast to the syndromes discussed here, these disorders have an increased risk of sudden cardiac death (SCD). (See  <a class="medical medical_review" href="/d/html/916.html" rel="external">"Catecholaminergic polymorphic ventricular tachycardia"</a> and  <a class="medical medical_review" href="/d/html/4931.html" rel="external">"Arrhythmogenic right ventricular cardiomyopathy: Anatomy, histology, and clinical manifestations", section on 'Ventricular arrhythmias'</a> and  <a class="medical medical_review" href="/d/html/106759.html" rel="external">"Brugada syndrome: Clinical presentation, diagnosis, and evaluation"</a>.)</p><p>Previously reported series of idiopathic VT and VF are likely to include a heterogeneous group of patients with various diagnoses and prognoses. Currently, idiopathic VT generally refers to one of the three benign syndromes described here and excludes patients with other diagnoses.</p><p class="headingAnchor" id="H7832199"><span class="h2">Sites of origin</span><span class="headingEndMark"> — </span>Idiopathic VT, or VT not associated with structural organic heart disease, can arise in several locations:</p><p class="bulletIndent1"><span class="glyph">●</span>Right ventricular outflow tract (also called repetitive monomorphic VT)</p><p class="bulletIndent1"><span class="glyph">●</span>Tricuspid annulus</p><p class="bulletIndent1"><span class="glyph">●</span>Right ventricle</p><p class="bulletIndent1"><span class="glyph">●</span>Left ventricle</p><p class="bulletIndent1"><span class="glyph">●</span>Inferoapical septum</p><p class="bulletIndent1"><span class="glyph">●</span>Left ventricular outflow tract</p><p class="bulletIndent1"><span class="glyph">●</span>Aortic cusps</p><p></p><p>These arrhythmias, not as rare as previously thought, are susceptible to radiofrequency ablation [<a href="#rid3">3</a>]. (See <a class="local">'Radiofrequency ablation'</a> below.)</p><p class="headingAnchor" id="H12026071"><span class="h2">Classification</span><span class="headingEndMark"> — </span>Multiple classification schemata for idiopathic VT appear in the literature. Investigations of idiopathic VT syndromes have focused for the most part on individual aspects of the syndrome (eg, clinical presentation, electrocardiographic appearance, electrophysiologic mechanism, response to antiarrhythmic agents); this approach has yielded a bewildering amount of often conflicting information. Despite this confusion, most investigators acknowledge the existence of at least three syndromes of idiopathic monomorphic VT:</p><p class="bulletIndent1"><span class="glyph">●</span>Repetitive monomorphic VT, also called right ventricular outflow tract (RVOT) VT, is a triggered arrhythmia that is characterized by frequent short "salvos" of nonsustained VT. Less commonly, arrhythmias with similar characteristics and mechanisms originate from the LVOT, and these are considered a variant of RVOT VT.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Paroxysmal sustained VT, which also arises from the RV, and is sometimes considered a sustained variant of repetitive monomorphic VT.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Idiopathic left ventricular tachycardia, which differs from the LVOT variant of RVOT VT in both the mechanism (reentry) and site of origin (inferoapex or midseptum).</p><p></p><p>These three syndromes effectively characterize the majority of patients with idiopathic monomorphic VT and often unite clinical presentation, ECG morphology, and anatomic location into recognizable syndromes  (<a class="graphic graphic_table graphicRef54842" href="/d/graphic/54842.html" rel="external">table 1</a>) [<a href="#rid1">1,2</a>]. In fact, however, idiopathic VT can arise from virtually any area of the heart, and other typical locations include the RV and LV inflow areas and the papillary muscles. The syndromes discussed in this section are by far the most frequently observed.</p><p>Bundle branch reentrant VT is a special form of monomorphic VT that typically occurs in patients with structural heart disease. Patients with BBRVT often have a baseline nonspecific conduction delay or left bundle branch block, and most have a prolonged His-to-ventricle time (ie, HV interval). (See  <a class="medical medical_review" href="/d/html/899.html" rel="external">"Bundle branch reentrant ventricular tachycardia"</a>.)</p><p class="headingAnchor" id="H3"><span class="h2">Idiopathic VT</span><span class="headingEndMark"> — </span>Idiopathic VT has accounted for approximately 10 percent all patients referred for evaluation of VT [<a href="#rid1">1</a>]. The mean age of patients with idiopathic VT is less than that of patients with VT secondary to underlying heart disease.</p><p>It is important to recognize that not all VT that occurs in the apparent absence of structural heart disease is idiopathic VT. Distinguishing idiopathic VT from other monomorphic VT syndromes is important for several reasons:</p><p class="bulletIndent1"><span class="glyph">●</span>Idiopathic VT is generally considered to have an excellent prognosis in terms of freedom from both the development of structural heart disease and arrhythmic death [<a href="#rid4">4-10</a>]. There are several exceptions to this generalization, however, and episodes of SCD can occur [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Idiopathic VT often responds to antiarrhythmic drugs that would be unhelpful or even contraindicated in VT occurring in the setting of coronary heart disease.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Most idiopathic VT syndromes are now amenable to cure with catheter ablation techniques.</p><p></p><p class="headingAnchor" id="H4"><span class="h2">Other ventricular tachyarrhythmias</span><span class="headingEndMark"> — </span>In addition to monomorphic VT, both polymorphic VT and VF can occur in the absence of structural heart disease. In contrast to the generally good prognosis associated with idiopathic monomorphic VT, these syndromes are associated with an increased risk of SCD. (See  <a class="medical medical_review" href="/d/html/1019.html" rel="external">"Approach to sudden cardiac arrest in the absence of apparent structural heart disease"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Polymorphic VT in the absence of structural heart disease occurs in two settings: with a prolonged QT interval in acquired or inherited long QT syndrome; and with a normal QT interval in usually familial disease, which is also called catecholaminergic polymorphic VT. (See  <a class="medical medical_review" href="/d/html/1036.html" rel="external">"Congenital long QT syndrome: Epidemiology and clinical manifestations"</a> and  <a class="medical medical_review" href="/d/html/916.html" rel="external">"Catecholaminergic polymorphic ventricular tachycardia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>VF in the absence of structural heart disease or other reversible arrhythmic triggers (eg, ischemia or metabolic derangements) is also referred to as idiopathic. The diagnosis of idiopathic VF is considered only after all other causes of VF have been rigorously excluded. The rationale for this approach comes from autopsy studies of SCD in previously healthy individuals. These studies found an appreciable incidence of coronary heart disease (most without a previous history of chest pain), hypertrophic cardiomyopathy, myocarditis, and ARVC. Brugada syndrome is a specific cause of lethal ventricular arrhythmias in patients without structural heart disease; it is characterized by ST elevation in the anterior precordial leads on the resting surface electrocardiogram. (See  <a class="medical medical_review" href="/d/html/106759.html" rel="external">"Brugada syndrome: Clinical presentation, diagnosis, and evaluation"</a> and  <a class="medical medical_review" href="/d/html/1019.html" rel="external">"Approach to sudden cardiac arrest in the absence of apparent structural heart disease", section on 'Idiopathic VF'</a>.)</p><p></p><p class="headingAnchor" id="H5"><span class="h1">DIAGNOSTIC EVALUATION</span><span class="headingEndMark"> — </span>By definition, patients with idiopathic monomorphic VT have no detectable structural heart disease [<a href="#rid1">1,2,4-9</a>]. Thus, the assessment of these patients focuses upon establishing the presence of a normal heart. The evaluation of the patient with sustained ventricular arrhythmias and sudden death is reviewed in detail separately. (See  <a class="medical medical_review" href="/d/html/1029.html" rel="external">"Sustained monomorphic ventricular tachycardia: Clinical manifestations, diagnosis, and evaluation", section on 'Additional diagnostic evaluation'</a> and  <a class="medical medical_review" href="/d/html/970.html" rel="external">"Cardiac evaluation of the survivor of sudden cardiac arrest"</a>.)</p><p class="headingAnchor" id="H6"><span class="h2">General approach</span><span class="headingEndMark"> — </span>For the purposes of this review, the following summarizes findings that may be seen in patients with idiopathic monomorphic VT:</p><p class="bulletIndent1"><span class="glyph">●</span>The resting ECG is typically normal between arrhythmia episodes, although some patients have temporary ECG repolarization abnormalities immediately after VT termination.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The signal averaged ECG recorded during sinus rhythm is usually normal, although abnormalities may be seen during VT [<a href="#rid6">6,11</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Functional studies of left ventricular (LV) and right ventricular (RV) performance during sinus rhythm are normal, although segmental wall motion abnormalities may be seen immediately after VT termination. In patients who have not had a recent episode of VT, abnormalities in ventricular function should suggest an alternative diagnosis. (See  <a class="medical medical_review" href="/d/html/970.html" rel="external">"Cardiac evaluation of the survivor of sudden cardiac arrest", section on 'Echocardiography'</a>.)</p><p></p><p class="bulletIndent1">However, in rare cases, LV dysfunction can occur as a consequence of idiopathic VT, due to a tachycardia-induced cardiomyopathy. Such a myopathy can develop without persistent tachycardia if there are very frequent PVCs (ie, &gt;20,000 per day) [<a href="#rid12">12</a>]. This is a very important condition to recognize, as the LV dysfunction is reversible with treatment of the arrhythmia. (See  <a class="medical medical_review" href="/d/html/1062.html" rel="external">"Arrhythmia-induced cardiomyopathy", section on 'Frequent ventricular ectopy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The exercise stress test should be normal. Coronary angiography, which is considered in patients with minimally symptomatic arrhythmias only if the stress test suggests ischemia, should also be normal.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiovascular magnetic resonance imaging (CMR) may reveal mild structural abnormalities of the RV in patients with RMVT, primarily involving the free wall (focal thinning, fatty infiltration, and wall motion abnormalities) [<a href="#rid13">13-15</a>]. The significance of these changes is unclear, since there is a poor correlation between the origin of the RMVT and the site of the CMR abnormalities unless they are also present in the RVOT.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Limited data suggest that RV radionuclide myocardial perfusion imaging can distinguish between idiopathic monomorphic VT and VT due to an organic cause such as dilated cardiomyopathy, myocarditis, or ARVC [<a href="#rid16">16</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>RV biopsy, which is rarely performed, is usually normal, although a number of studies have reported abnormalities that are nonspecific and of no significant value [<a href="#rid17">17-19</a>].</p><p></p><p class="headingAnchor" id="H7"><span class="h2">Distinction from ARVC</span><span class="headingEndMark"> — </span>RMVT can be particularly difficult to distinguish from the more serious disorder, ARVC. Although ARVC is unlikely in patients who have a normal signal averaged electrocardiogram and normal imaging studies of RV size and function, the "development" of ARVC in patients thought to have idiopathic VT at presentation has been reported [<a href="#rid9">9,20</a>]. </p><p>Thus, the clinical boundaries between idiopathic RV tachycardia and ARVC may be difficult to establish in atypical cases. The findings on the ECG, signal averaged ECG, and electrophysiology (EP) studies may be helpful in making this distinction:</p><p class="bulletIndent1"><span class="glyph">●</span>The resting ECG can be normal at presentation in approximately 40 percent of patients with ARVC. However, characteristic abnormalities of ARVC develop in almost all patients within six years of presentation [<a href="#rid21">21</a>]. In a cohort of 59 patients (17 with ARVC, 42 with RMVT), ECG features suggestive of ARVC included longer mean QRS duration in lead I (150 versus 123 msec in RMVT), precordial transition in lead V6 (18 versus 0 percent in RMVT), and at least one lead with QRS notching (65 versus 21 percent in RMVT) [<a href="#rid22">22</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The signal averaged ECG in the time domain is typically abnormal in ARVC, but usually normal in idiopathic RV tachycardia [<a href="#rid11">11</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>On EP study, four findings are seen in most patients with ARVC but are rare in idiopathic RV tachycardia: inducible VT by programmed stimulation; multiple VT morphologies; fractionated diastolic electrograms during VT or sinus rhythm at the VT site of origin or other RV sites; and regions of low amplitude and prolonged duration on intracardiac electrograms [<a href="#rid23">23-25</a>]. (See <a class="local">'Electrophysiologic features'</a> below.)</p><p></p><p class="headingAnchor" id="H9"><span class="h1">REPETITIVE MONOMORPHIC VT</span><span class="headingEndMark"> — </span>Repetitive monomorphic VT (RMVT) is characterized by frequent short "salvos" of monomorphic nonsustained VT  (<a class="graphic graphic_waveform graphicRef66679" href="/d/graphic/66679.html" rel="external">waveform 1</a>). It was first described by Gallavardin in 1922 and is variously described in the literature as RMVT, RV tachycardia, RVOT tachycardia, catecholamine-sensitive VT, adenosine-sensitive VT, and exercise-induced VT. Approximately 10 to 15 percent of cases arise from the left ventricular outflow tract [<a href="#rid26">26-28</a>].</p><p>Although RMVT is considered to occur in "normal" hearts, static and cine-magnetic resonance imaging often reveal mild structural abnormalities of the RV, primarily involving the free wall (focal thinning, fatty infiltration, and wall motion abnormalities) [<a href="#rid13">13-15</a>]. The functional significance of these changes is uncertain. In the few cases studied, DNA from myocardial biopsies of ventricular muscle has been normal [<a href="#rid29">29</a>].</p><p class="headingAnchor" id="H10"><span class="h2">Epidemiology and clinical features</span><span class="headingEndMark"> — </span>RMVT occurs almost exclusively in young to middle-aged patients without structural heart disease [<a href="#rid1">1,2,4-9</a>]. There has generally been no predilection on the basis of sex, although a 2:1 female predominance was observed in one report [<a href="#rid26">26</a>]. A surprising number of competitive athletes (particularly cyclists) are identified in many series of RMVT.</p><p>The most common associated symptoms are palpitations and lightheadedness during episodes [<a href="#rid5">5,6</a>]. In one illustrative report of 18 patients, twelve had symptomatic arrhythmia, two of whom had syncope, and six were completely asymptomatic.</p><p>Most arrhythmias are nonsustained (usually 3 to 15 beats), but up to one-half of patients have some sustained episodes, and some patients have only sustained VT [<a href="#rid6">6,9,13,30</a>]. (See <a class="local">'Paroxysmal sustained VT'</a> below.) </p><p>Bursts of nonsustained VT are typically provoked by emotional stress or exercise, often occurring during the "warm-down" period after exercise, a time when circulating catecholamines are at peak levels [<a href="#rid5">5,6,8</a>]. There may also be a circadian pattern, with prominent peaks between 7 and 11 AM and 4 and 8 PM, correlating with periods of increased sympathetic activity [<a href="#rid31">31</a>]. In some patients, a critical "window" of heart rates (upper and lower thresholds) that result in occurrence of the arrhythmia can be defined [<a href="#rid27">27</a>].</p><p>The inducibility of RMVT by stress or catecholamine infusion is suggestive of an abnormality in cardiac sympathetic function. Consistent with this hypothesis is evidence of regional cardiac sympathetic denervation in some patients with RMVT and structurally normal hearts (five of nine compared with zero of nine controls in one report) [<a href="#rid32">32</a>]. Patients with RMVT may also have regions of impaired neuronal reuptake of norepinephrine, leading to increased local synaptic catecholamine concentrations and downregulation of myocardial beta adrenergic receptors [<a href="#rid33">33</a>].</p><p>There may also be sex-specific triggers. In a report of 47 men and women with RMVT, states of hormonal flux (premenstrual, gestational, perimenopausal, administration of birth control pills) were the most common trigger for RMVT in 59 percent of women and were the only recognizable triggers in 41 percent [<a href="#rid34">34</a>]. Men were more likely than women to identify exercise, stress, or caffeine as a trigger (92 versus 41 percent).</p><p class="headingAnchor" id="H11"><span class="h2">Site of origin</span><span class="headingEndMark"> — </span>RV tachycardias usually originate from the septal aspect of the RVOT [<a href="#rid6">6,26,28,35-38</a>]. A nine site mapping schema of the septal RVOT has proven useful in localizing RVOT tachycardias on the basis of their 12 lead ECG morphology  (<a class="graphic graphic_figure graphicRef72301" href="/d/graphic/72301.html" rel="external">figure 1</a>) [<a href="#rid39">39</a>].</p><p>RV tachycardias typically arise from a very narrow area just inferior to the pulmonary valve in the anterior aspect of the RVOT [<a href="#rid37">37</a>]. Endocardial mapping in such patients shows that the earliest site of endocardial activation occurs in this region [<a href="#rid6">6,9</a>].</p><p>Less commonly, sites of origin have been mapped to the RV inflow tract, the free wall of the RVOT, the root of the pulmonary artery, the left and right aortic sinus of Valsalva, the left ventricle, the mitral annulus, and the papillary muscles [<a href="#rid26">26,36,38,40-49</a>].</p><p class="headingAnchor" id="H12"><span class="h2">Electrocardiographic features</span><span class="headingEndMark"> — </span>The typical rate of RMVT ranges from 140 to 180 beats/min, and may fluctuate based upon catecholamine levels. The VT cycle length often prolongs prior to termination.</p><p class="headingAnchor" id="H13"><span class="h3">RV outflow tract</span><span class="headingEndMark"> — </span>The majority of RMVT episodes have a characteristic ECG appearance with two main features [<a href="#rid1">1,2,4-9,39</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Left bundle branch block</p><p class="bulletIndent1"><span class="glyph">●</span>Inferior axis</p><p></p><p>This morphology is consistent with the RVOT origin seen by catheter ablation and endocardial mapping [<a href="#rid6">6,37</a>]. This ECG "signature" accounts for at least 70 percent of all idiopathic VTs [<a href="#rid1">1</a>].</p><p>The ECG pattern of RV tachycardia initiation may provide information about the site of origin and the arrhythmogenic mechanism as illustrated by the following observations:</p><p class="bulletIndent1"><span class="glyph">●</span>In a series of 32 patients with exercise-induced RMVT, VT usually began without a change in cycle length. Arrhythmias that initiated in this manner had an inferior axis, and appeared to be related to triggered activity due to delayed afterpotentials [<a href="#rid50">50</a>]. By comparison, VT initiated with a long-short sequence was more often nonsustained and often had a superior axis, suggesting an origin in the body or septal region of the ventricle; the mechanism for this VT is probably early afterpotentials.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a report of 14 patients, those with septal compared with free wall sites were significantly less likely to have notching of the QRS complex (29 versus 95 percent) and more likely to show early precordial transition by lead V4 (79 versus 5 percent) [<a href="#rid51">51</a>]. In addition, a positive R wave in lead I distinguished posterior from anterior septal and free wall sites.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The degree of similarity of 12-lead ECG waveforms between VT and a pace map can be used to estimate the likelihood of successful ablation at that site. (See <a class="local">'Radiofrequency ablation'</a> below.)</p><p></p><p>The majority of patients with RV tachycardia have a single ECG morphology [<a href="#rid23">23</a>]. However, occasional patients present with multiple tachycardia morphologies arising from discrete sites in the RVOT [<a href="#rid52">52</a>]. The presence of multiple left bundle VT morphologies, particularly during EP study, should suggest the possibility of ARVC [<a href="#rid23">23,53,54</a>]. (See <a class="local">'Distinction from ARVC'</a> above.)</p><p class="headingAnchor" id="H14"><span class="h3">LV outflow tract</span><span class="headingEndMark"> — </span>Electrocardiographic criteria have also been described for RMVT originating in the LVOT [<a href="#rid26">26,27</a>]. In a series of 33 patients with RMVT, four (12 percent) had LV sites of origin that could be predicted by two patterns [<a href="#rid26">26</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A right bundle, inferior axis morphology with a monophasic R wave in V1 that arose from the left fibrous trigone  (<a class="graphic graphic_waveform graphicRef81690" href="/d/graphic/81690.html" rel="external">waveform 2</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A pattern similar to typical RMVT from the RVOT (left bundle, inferior axis) except that the precordial transition was earlier (at V2 for the LVOT as compared with V3 or later for the RVOT).</p><p></p><p>Other reports have characterized unique QRS morphologies for idiopathic VT arising from the sinuses of Valsalva [<a href="#rid9">9,43,44</a>]. Although there is some interindividual variability, premature ventricular complex/contraction (PVC; also referred to a premature ventricular beats or premature ventricular depolarizations) arising from the left aortic sinus tend to be negative in lead I and have a "w" pattern in V1, while PVC with a broad R wave in V1 is characteristic of a right aortic cusp origin. The precordial R wave transition is much earlier when VT originates from either aortic sinus of Valsalva compared with the RVOT, since the LVOT is posterior to the RVOT [<a href="#rid44">44</a>].</p><p class="headingAnchor" id="H15"><span class="h2">Electrophysiologic features</span><span class="headingEndMark"> — </span>RMVT can be induced in the EP laboratory, although usually not with programmed stimulation [<a href="#rid5">5,6,23,27,55</a>]. In most patients, sustained or nonsustained episodes occur in response to burst atrial or ventricular pacing, and are greatly facilitated by <a class="drug drug_general" data-topicid="8578" href="/d/drug information/8578.html" rel="external">isoproterenol</a> or <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a> infusion [<a href="#rid5">5,6,27,30,55</a>].</p><p>These electrophysiologic observations suggest that triggered activity due to delayed afterpotentials, rather than reentry, is the mechanism of RMVT. The response to "pharmacologic probes" further strengthens this hypothesis. RMVT has been terminated with <a class="drug drug_general" data-topicid="9359" href="/d/drug information/9359.html" rel="external">adenosine</a>, <a class="drug drug_general" data-topicid="10043" href="/d/drug information/10043.html" rel="external">verapamil</a>, and beta blockers, all of which interfere with the cAMP-mediated slow inward calcium current [<a href="#rid29">29,40,56-58</a>].</p><p>These observations are consistent with the hypothesis that RMVT results from triggered activity induced by cAMP-mediated delayed after depolarizations (DADs) [<a href="#rid30">30,59</a>]. The increase in cAMP activity may, at least in some patients, result from an acquired somatic cell mutation in the inhibitory G protein G-alpha-i2 at the site of the arrhythmogenic focus [<a href="#rid59">59,60</a>].</p><p>However, the lack of specificity of these probes and the absence of a uniform response supports the general consensus that the mechanism of RMVT is incompletely characterized and may vary among individuals. Additional support for other mechanisms is based upon the observation that the tachycardia may, in some patients, terminate with overdrive pacing, ventricular extrastimulation, or autonomic modulation using Valsalva maneuver or carotid sinus pressure [<a href="#rid9">9</a>].</p><p>EP studies may also help distinguish RMVT occurring in the absence of structural heart disease from that in ARVC [<a href="#rid23">23,24</a>]. (See <a class="local">'Distinction from ARVC'</a> above.) </p><p class="headingAnchor" id="H16"><span class="h2">Prognosis</span><span class="headingEndMark"> — </span>The prognosis of RMVT is almost uniformly good [<a href="#rid4">4-9,55</a>]. The following observations from early studies illustrate the range of findings:</p><p class="bulletIndent1"><span class="glyph">●</span>Two initial series evaluated 30 and 18 patients [<a href="#rid5">5,6</a>]. The arrhythmia responded to a variety of antiarrhythmic drugs, including type I drugs and <a class="drug drug_general" data-topicid="9829" href="/d/drug information/9829.html" rel="external">propranolol</a>. At a mean of 30 months in one study and a range of 0.5 to 8 years in the other, there were no deaths or episodes of cardiac arrest [<a href="#rid5">5,6</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A third report consisted of 24 young patients, most of whom had RV tachycardia and two-thirds of whom were symptomatic [<a href="#rid7">7</a>]. At a mean follow-up of 7.5 years, three patients died suddenly; none was taking antiarrhythmic drugs at the time. The SCD events may have been due to RMVT itself, although patients with other syndromes now known to be malignant may have been included (eg, Brugada syndrome, arrhythmogenic right ventricular cardiomyopathy). Alternatively, a tachycardia-induced cardiomyopathy may have predisposed patients to additional arrhythmias. (See  <a class="medical medical_review" href="/d/html/1062.html" rel="external">"Arrhythmia-induced cardiomyopathy"</a>.)</p><p></p><p class="headingAnchor" id="H17"><span class="h3">Malignant variant</span><span class="headingEndMark"> — </span>More recent studies in which these other syndromes were unlikely have identified a malignant variant of RMVT. Polymorphic VT and VF, which are malignant arrhythmias, have been demonstrated in patients with RMVT [<a href="#rid61">61,62</a>]. In one series, three patients with RMVT later developed VF. In these patients, PVCs were more closely coupled to prior beats than is usual for RMVT [<a href="#rid61">61</a>]. It was postulated that relatively early triggered beats occurred in a vulnerable period during repolarization, resulting in VF.</p><p>In a subsequent report, 16 patients with frequent PVCs from the RVOT were noted to have polymorphic VT or VF that was initiated by one of the PVCs [<a href="#rid62">62</a>]. In contrast to the first study, the coupling interval of the PVCs in patients who developed malignant arrhythmias was not different from that in 85 other patients with RMVT who did not have malignant arrhythmias. Radiofrequency (RF) ablation successfully eliminated the RVOT PVCs in 13 patients and modified the PVCs in the other three. Over a mean follow-up of 54 months, none had recurrent VF or syncope. (See <a class="local">'Radiofrequency ablation'</a> below.)</p><p>The prevalence of this malignant variant, and whether it represents a distinct disorder from RMVT, is unclear. The high frequency in the above study (16 of 101 patients) is probably a substantial overestimate due to referral bias. In addition, it is possible that some cases categorized as polymorphic VT were simply the common form of RVOT VT in which QRS morphology varied during the tachycardia due to fluctuations in loading conditions. An editorial accompanying this report addressed the issue of whether RF ablation should now be considered in all patients with RMVT [<a href="#rid63">63</a>]. Due to the relatively high prevalence of RVOT PVCs, the rarity of malignant RVOT VT/VF, it is reasonable to focus concern on patients with the following higher risk characteristics:</p><p class="bulletIndent1"><span class="glyph">●</span>A history of syncope</p><p class="bulletIndent1"><span class="glyph">●</span>Very fast VT (&gt;230 beats/min)</p><p class="bulletIndent1"><span class="glyph">●</span>Very frequent ectopy (&gt;20,000 PVCs/day)</p><p class="bulletIndent1"><span class="glyph">●</span>PVCs with a short coupling interval</p><p></p><p class="headingAnchor" id="H18"><span class="h2">Treatment of RMVT</span><span class="headingEndMark"> — </span>Therapeutic decisions for RMVT should consider that many patients are young and otherwise healthy. As a result, ablative therapy may be preferable to chronic administration of antiarrhythmic drugs.</p><p class="headingAnchor" id="H19"><span class="h3">Medical therapy</span><span class="headingEndMark"> — </span>Medical therapy serves two roles in RMVT: termination of the arrhythmia; and prevention of recurrence. RMVT can be terminated with <a class="drug drug_general" data-topicid="9359" href="/d/drug information/9359.html" rel="external">adenosine</a> and beta blockers, all of which interfere with the cAMP-mediated slow inward calcium current [<a href="#rid29">29,40,56-58</a>].</p><p>For prevention of recurrence, beta blockers are often used as first-line agents. These drugs are attractive since their side effect profiles are mild in comparison with antiarrhythmic agents [<a href="#rid64">64</a>]. </p><p><a class="drug drug_general" data-topicid="9829" href="/d/drug information/9829.html" rel="external">Propranolol</a> has prevented recurrence in as many as 14 of 22 patients with a typical RVOT origin of RMVT [<a href="#rid6">6,65</a>]. However, other studies have found that these agents were much less likely to prevent recurrent RMVT, although the combination of a beta blocker with a class I drug may be useful [<a href="#rid9">9,55</a>].</p><p>Class I antiarrhythmic agents  (<a class="graphic graphic_table graphicRef120433" href="/d/graphic/120433.html" rel="external">table 2</a>) alone are helpful in some patients. However, class III drugs (<a class="drug drug_general" data-topicid="9941" href="/d/drug information/9941.html" rel="external">sotalol</a> and <a class="drug drug_general" data-topicid="8595" href="/d/drug information/8595.html" rel="external">amiodarone</a>) may be preferred, especially in patients with arrhythmia that is refractory to other drugs [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H20"><span class="h3">Radiofrequency ablation</span><span class="headingEndMark"> — </span>Due to the limited efficacy and potential side effects of antiarrhythmic drugs, there has been increasing use of radiofrequency (RF) ablation in patients with symptomatic RMVT. Professional society guidelines for the management of ventricular arrhythmias and the prevention of SCD indicate that there is evidence and/or general agreement supporting RF ablation in patients with symptomatic idiopathic VT that is drug-refractory, or in such patients who are intolerant of drugs or do not desire long-term drug therapy [<a href="#rid64">64</a>].</p><p>The 2019 HRS/EHRA/APHRS/LAHRS Expert Consensus Statement on Catheter Ablation of Ventricular Arrhythmias recommended catheter ablation in the following patients with idiopathic VT and without structural heart disease [<a href="#rid66">66,67</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Severely symptomatic patients with monomorphic VT.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Monomorphic VT in patients in whom antiarrhythmic drugs are not effective, not tolerated, or not desired.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with recurrent sustained polymorphic VT and VF (electrical storm) that is refractory to antiarrhythmic therapy when there is a suspected trigger that can be targeted for ablation.</p><p></p><p>Success rates for RF catheter ablation range from 80 to 100 percent [<a href="#rid28">28,35,36,40,41,68</a>]. The success rate depends in part upon the location of the focus; the success of catheter ablation for idiopathic VTs in atypical positions is generally not as high as for RVOT locations [<a href="#rid36">36</a>]. The degree of similarity of 12-lead ECG waveforms between VT and a pace map can be used to estimate the likelihood of successful ablation at that site [<a href="#rid69">69</a>]. A mean absolute deviation &gt;12 percent suggests sufficient dissimilarity to dissuade ablation at that site.</p><p>Although successful ablation of LVOT tachycardia has been performed using an endocardial approach, coronary venous mapping and percutaneous approaches to the pericardial space have shown that some of these VTs arise from the LV epicardium [<a href="#rid28">28,45,46,68,70</a>]. There have also been several reports of successful ablation of RMVT from the left and right sinuses of Valsalva [<a href="#rid43">43</a>].</p><p>Radiofrequency ablation is generally associated with a low rate of procedural complications [<a href="#rid28">28,35-38,40</a>]. (See  <a class="medical medical_review" href="/d/html/1007.html" rel="external">"Overview of catheter ablation of cardiac arrhythmias", section on 'Complications'</a>.)</p><p>Long term follow-up of patients successfully treated with radiofrequency catheter ablation is limited. In two reports of 42 patients in whom all tachycardias were successfully ablated, only five (12 percent) had a detected recurrence during a 2 to 50 month follow-up [<a href="#rid68">68,71</a>].</p><p>The likelihood of successful ablation may be less when the site of origin is not endocardial or not definitively identified during mapping [<a href="#rid68">68</a>]. In a review of 75 patients with presumed RVOT VT, the inability to identify a focus, and therefore the success rate, correlated with the QRS duration in lead V2 [<a href="#rid72">72</a>]. The success rate was 95 percent when the QRS duration in V2 during pace mapping was ≥160 ms in duration compared with only 54 percent when the QRS duration was &lt;160 ms. Left-sided and epicardial ablation strategies were not pursued in this experience.</p><p class="headingAnchor" id="H29141861"><span class="h4">Epicardial ablation</span><span class="headingEndMark"> — </span>A possible explanation for failed radiofrequency ablation is that the arrhythmia arises from an epicardial rather than an endocardial focus. In one report of failed ablation (either acute failure of the procedure or late recurrence of arrhythmia) in 30 patients with VT (15 with apparently normal hearts), subxiphoid instrumentation of the pericardial space was used for both epicardial mapping and ablation [<a href="#rid70">70</a>]. Twenty-four of the VTs appeared to originate from the epicardium; 17 were successfully ablated, while the other seven had sites that were inaccessible primarily due to interference from the left atrial appendage. Six of these seven patients could be ablated from the left coronary cusp.</p><p class="headingAnchor" id="H21"><span class="h1">PAROXYSMAL SUSTAINED VT</span><span class="headingEndMark"> — </span>Paroxysmal sustained VT is another clinical syndrome of idiopathic right ventricular tachycardia that resembles RMVT in many ways [<a href="#rid6">6,9,13,73</a>]. The most frequent QRS morphology is a left bundle branch block with an inferior axis, and the typical site of origin is the superior septal aspect of the RVOT. Furthermore, patients with paroxysmal sustained VT appear to respond to antiarrhythmic agents, particularly <a class="drug drug_general" data-topicid="9359" href="/d/drug information/9359.html" rel="external">adenosine</a>, in a manner similar to patients with RMVT, although data are limited [<a href="#rid73">73</a>].</p><p>Because of these similarities, it is not clear if paroxysmal sustained VT is a distinct clinical syndrome. Compared with nonsustained RMVT, this disorder is more often symptomatic and less often exercise-provoked. It is also more frequently induced by programmed stimulation, although <a class="drug drug_general" data-topicid="8578" href="/d/drug information/8578.html" rel="external">isoproterenol</a> may facilitate induction in some cases.</p><p>On the other hand, some investigators dispute the existence of paroxysmal sustained VT as a syndrome distinct from RMVT. One study, for example, found that 58 percent of patients with RMVT had at least one episode of sustained VT [<a href="#rid9">9</a>]. In addition, electrophysiologic studies may reproduce sustained VT in patients who present with only nonsustained VT (particularly during <a class="drug drug_general" data-topicid="8578" href="/d/drug information/8578.html" rel="external">isoproterenol</a> infusion) or vice versa. It has also been suggested that the incidence of sudden cardiac death in RMVT is actually due to overlap with paroxysmal sustained VT. For these reasons, the two syndromes are occasionally considered together as idiopathic right ventricular tachycardia, or simply as RMVT.</p><p class="headingAnchor" id="H22"><span class="h1">IDIOPATHIC LEFT VENTRICULAR TACHYCARDIA</span><span class="headingEndMark"> — </span>Idiopathic left ventricular tachycardia (ILVT) was first described in 1979 [<a href="#rid74">74</a>]. Belhassen was the first to report the characteristic termination of this VT with intravenous <a class="drug drug_general" data-topicid="10043" href="/d/drug information/10043.html" rel="external">verapamil</a> [<a href="#rid75">75</a>], accounting for its two descriptive eponyms: Belhassen VT and verapamil-responsive VT.</p><p class="headingAnchor" id="H23"><span class="h2">Clinical features</span><span class="headingEndMark"> — </span>The typical patient with ILVT presents at age 20 to 40, but often reports symptomatic episodes dating back to adolescence. The clinical characteristics of ILVT appear to be more uniform than those of the idiopathic RV tachycardias [<a href="#rid10">10,75-80</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>It has a more variable association with physical activity, and is not usually provoked by exercise.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>It frequently produces symptoms such as palpitations and presyncope; syncope is uncommon.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac arrest is rare, but isolated cases have been reported [<a href="#rid78">78</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tachycardia-related cardiomyopathy has been reported, but is unusual since episodes are typically infrequent.</p><p></p><p class="headingAnchor" id="H24"><span class="h2">Site of origin</span><span class="headingEndMark"> — </span>Endocardial mapping during the VT demonstrates that the site of earliest activation is the inferoseptal region of the left ventricle in patients with a left frontal axis [<a href="#rid10">10</a>]. Mapping for catheter ablation also consistently localizes this VT to the inferior aspect of the midseptal region [<a href="#rid81">81</a>]. By comparison, the anterosuperior left ventricle is the initial site in those patients with VT that has a right frontal axis [<a href="#rid10">10,78,82</a>].</p><p class="headingAnchor" id="H25"><span class="h2">Electrocardiographic features</span><span class="headingEndMark"> — </span>Corresponding to its left ventricular origin, ILVT has a right bundle branch block morphology with a left superior frontal plane axis and a relatively narrow QRS duration (typically 0.12 to 0.14 sec)  (<a class="graphic graphic_waveform graphicRef64279" href="/d/graphic/64279.html" rel="external">waveform 3</a>). A small subset of patients with ILVT has a right frontal plane (2 of 16 in one report) [<a href="#rid10">10</a>].</p><p>ILVT is often confused with supraventricular tachycardia because of its characteristic ECG morphology, and the response to <a class="drug drug_general" data-topicid="10043" href="/d/drug information/10043.html" rel="external">verapamil</a> (see below). </p><p>The signal averaged ECG in the time domain is usually normal during sinus rhythm. However, frequency analysis using fast Fourier transform has shown an abnormal high-frequency component of the initial portion of the QRS complex that may distinguish these patients from normals [<a href="#rid83">83</a>].</p><p class="headingAnchor" id="H26"><span class="h2">Electrophysiologic features</span><span class="headingEndMark"> — </span>ILVT is typically reproduced in the electrophysiology laboratory using programmed stimulation employing extrastimuli and, on occasion, with rapid atrial or ventricular pacing [<a href="#rid10">10,38,74-80</a>]. In contrast to RMVT, ILVT is not usually provoked by <a class="drug drug_general" data-topicid="8578" href="/d/drug information/8578.html" rel="external">isoproterenol</a> infusion.</p><p>These observations, coupled with the response of ILVT to pacing (entrainment), support a reentrant mechanism [<a href="#rid82">82</a>]. Further support for a reentrant mechanism comes from several mapping studies:</p><p class="bulletIndent1"><span class="glyph">●</span>One report identified a mid-diastolic potential and a single fused presystolic Purkinje potential at the VT exit site during VT [<a href="#rid84">84</a>]. This observation suggests a macroreentry circuit involving the normal Purkinje system and abnormal Purkinje tissue that manifests decremental properties and <a class="drug drug_general" data-topicid="10043" href="/d/drug information/10043.html" rel="external">verapamil</a> sensitivity.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A second study using electroanatomic mapping found that, during sinus rhythm, only patients with ILVT had a retrograde potential originating from the left posterior Purkinje fiber; diastolic potentials during ILVT coincided with the earliest retrograde Purkinje potential during sinus rhythm [<a href="#rid81">81</a>].</p><p></p><p>The His bundle is commonly activated early in a retrograde fashion during ILVT, and a distinct Purkinje spike typically precedes the onset of the QRS  (<a class="graphic graphic_diagnosticimage graphicRef51420" href="/d/graphic/51420.html" rel="external">image 1</a>) [<a href="#rid76">76</a>]. However, the retrograde His bundle deflection can be dissociated from the QRS complex by premature stimulation in the ventricle, atrium, or His region, implying that the reentrant circuit does not require the His bundle [<a href="#rid78">78,80</a>]. These findings also suggest that the posterior fascicle of the left bundle branch may be a part of, or at least in close proximity to the VT circuit  (<a class="graphic graphic_figure graphicRef68778 graphicRef76252" href="/d/graphic/68778.html" rel="external">figure 2A-B</a>). The terms fascicular ventricular tachycardia and fascicular tachycardia been used to describe this arrhythmia [<a href="#rid80">80,85,86</a>].</p><p class="headingAnchor" id="H27"><span class="h2">Treatment of ILVT</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="10043" href="/d/drug information/10043.html" rel="external">Verapamil</a> is usually effective in the treatment of ILVT, both for the termination of acute episodes and the prevention of recurrence [<a href="#rid10">10,78-80,85</a>]. Verapamil can be given 5 to 10 mg IV bolus over two minutes; if no response, an additional 10 mg IV bolus may be administered 15 to 30 minutes following the initial dose.</p><p>In one report, for example, intravenous <a class="drug drug_general" data-topicid="10043" href="/d/drug information/10043.html" rel="external">verapamil</a> terminated the arrhythmia in 13 of 14 patients and was effective in all five patients who required long-term oral therapy for symptom control [<a href="#rid10">10</a>]. By comparison, vagal maneuvers, beta blockers, and <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a> are often ineffective. There is little reported experience with the use of other antiarrhythmic drugs; the class III agents are the most effective among those tested, while class I drugs are rarely of benefit [<a href="#rid9">9</a>].</p><p>Catheter ablation has been performed with efficacy rates of 85 to 100 percent in patients with resistant or incessant ILVT or those intolerant of medications [<a href="#rid28">28,38,76,77,84,87</a>]. Selection of ablation target sites focuses on pace mapping techniques and/or activation mapping, with particular attention to the mid-diastolic potential and/or presystolic Purkinje activation [<a href="#rid76">76,84</a>]. Electroanatomic mapping and identification of the earliest retrograde Purkinje potential can also be used for guiding ablation [<a href="#rid81">81</a>].</p><p>Reported series of catheter ablation for ILVT, although small, have demonstrated a high rate of chronic arrhythmia control and relative freedom from procedural complications [<a href="#rid76">76,77,87</a>]. In one report, for example, 17 successfully ablated patients were followed for a mean of seven months [<a href="#rid77">77</a>]. No patient had a recurrent symptomatic tachyarrhythmia, and in the six who were and underwent repeat electrophysiology study, the tachycardia could not be induced.</p><p class="headingAnchor" id="H3880645476"><span class="h1">SPORADIC POLYMORPHIC VT IN THE STRUCTURALLY NORMAL HEART</span><span class="headingEndMark"> — </span>Polymorphic VT may present in patients with no significant structural heart disease and no family history who do not have catecholaminergic polymorphic VT (CPVT). One study evaluated 15 such patients who presented with syncope, presyncope, or cardiac arrest [<a href="#rid88">88</a>]. The arrhythmia was induced by exercise in four and by coronary vasospasm in two.</p><p>Electrophysiologic similarities may exist between rapid polymorphic VT in the normal heart and idiopathic ventricular fibrillation (VF). As an example, idiopathic VF is often initiated by a PVC with a very short coupling interval; polymorphic VT may also be preceded by a short-long-short cardiac cycle. (See  <a class="medical medical_review" href="/d/html/1019.html" rel="external">"Approach to sudden cardiac arrest in the absence of apparent structural heart disease", section on 'Idiopathic VF'</a>.) </p><p>Prior to making this diagnosis, cardiac catheterization with coronary angiography is necessary to exclude the presence of obstructive coronary artery disease. Some individuals with sporadic disease have undergone genetic testing; some but not all of these patients have de novo mutations similar to mutations observed in patients with familial disease, and have therefore been classified as having CPVT [<a href="#rid89">89-91</a>]. </p><p class="headingAnchor" id="H1208691324"><span class="h2">Chronic therapy</span><span class="headingEndMark"> — </span>There are presently no consensus treatment guidelines for the management of sporadic polymorphic VT in an otherwise normal heart. Therapy may be directed by the following observations:</p><p class="bulletIndent1"><span class="glyph">●</span>Chronic beta blocker administration may be effective in some patients whose polymorphic VT is reproducibly initiated by an infusion of <a class="drug drug_general" data-topicid="8578" href="/d/drug information/8578.html" rel="external">isoproterenol</a> or by exercise, a characteristic also seen with familial disease [<a href="#rid88">88</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The use of pacing, beta blockers, and calcium channel blockers alone or in combination may be effective if the arrhythmia is pause-dependent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Occasional patients with frequent uniform PVC triggering recurrent polymorphic VT or VF may be treated by catheter ablation of the PVCs when other methods fail.</p><p></p><p>However, an implantable cardioverter-defibrillator (ICD) is often the treatment of choice because patients with polymorphic VT and minimal or no structural heart disease are at risk for sudden death, and respond erratically to antiarrhythmic drugs [<a href="#rid88">88,92</a>]. Similar recommendations apply to patients with idiopathic VF. Pharmacologic or ablative therapy remains necessary in addition to the ICD for suppression of frequent arrhythmias (that result in ICD shocks). (See  <a class="medical medical_review" href="/d/html/83199.html" rel="external">"Early repolarization"</a>.)</p><p class="headingAnchor" id="H675608610"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/116416.html" rel="external">"Society guideline links: Inherited arrhythmia syndromes"</a> and  <a class="medical medical_society_guidelines" href="/d/html/115586.html" rel="external">"Society guideline links: Ventricular arrhythmias"</a> and  <a class="medical medical_society_guidelines" href="/d/html/112356.html" rel="external">"Society guideline links: Cardiac implantable electronic devices"</a> and  <a class="medical medical_society_guidelines" href="/d/html/116932.html" rel="external">"Society guideline links: Catheter ablation of arrhythmias"</a>.)</p><p class="headingAnchor" id="H28692643"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/15668.html" rel="external">"Patient education: Catheter ablation for the heart (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topic (see  <a class="medical medical_patient" href="/d/html/3449.html" rel="external">"Patient education: Catheter ablation for abnormal heartbeats (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H4068780"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Malignant ventricular arrhythmias usually occur in the presence of significant structural heart disease. Less commonly, ventricular tachycardia (VT) and ventricular fibrillation (VF) occur in hearts that appear normal but in fact, contain less visible abnormalities including derangements of cardiac ion channels or structural proteins. Idiopathic VT syndromes, including repetitive monomorphic VT, paroxysmal sustained VT, and idiopathic left ventricular tachycardia, occur in structurally normal hearts and have a more benign prognosis. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Idiopathic VT syndromes account for approximately 10 percent all patients referred for evaluation of VT, with the mean age of patients with an idiopathic VT being less than that of patients with VT secondary to underlying heart disease. Distinguishing an idiopathic VT syndrome from other monomorphic VT syndromes is important given the far better prognosis, greater array of antiarrhythmic drug options, and amenability to cure with ablation. (See <a class="local">'Idiopathic VT'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The diagnostic evaluation to establish the presence and type of heart disease in patients with sustained VT generally includes various invasive and noninvasive techniques, depending in part upon the clinical history and presentation. These include electrocardiography (ECG), echocardiography, exercise treadmill testing, signal averaged ECG, coronary angiography, endomyocardial biopsy, or magnetic resonance imaging. (See <a class="local">'General approach'</a> above and  <a class="medical medical_review" href="/d/html/1029.html" rel="external">"Sustained monomorphic ventricular tachycardia: Clinical manifestations, diagnosis, and evaluation", section on 'Additional diagnostic evaluation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Repetitive monomorphic VT (RMVT), also called right ventricular outflow tract (RVOT) VT, is a triggered arrhythmia that is characterized by frequent short "salvos" of nonsustained VT. The most common symptoms associated with RMVT are palpitations and lightheadedness, typically occurring during or immediately after exercise or emotional stress, although a significant proportion of patients are asymptomatic. Most RMVT episodes have a characteristic ECG appearance with left bundle branch block appearance and an inferior axis. (See <a class="local">'Repetitive monomorphic VT'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Treatment decisions for RMVT should consider that many patients are young and otherwise healthy, and as a result, ablative therapy may be preferable to chronic administration of antiarrhythmic drugs. RMVT can be terminated with <a class="drug drug_general" data-topicid="9359" href="/d/drug information/9359.html" rel="external">adenosine</a>, <a class="drug drug_general" data-topicid="10043" href="/d/drug information/10043.html" rel="external">verapamil</a>, and beta blockers, with beta blockers also often used as first-line agents to prevent recurrence. While class I and III antiarrhythmic drugs are effective in many patients, catheter ablation is frequently preferred given its high success rate and low rate of associated complications. (See <a class="local">'Treatment of RMVT'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Paroxysmal sustained VT is another clinical syndrome of idiopathic VT that resembles RMVT in many ways. The QRS morphology on ECG is frequently a left bundle branch block pattern with an inferior axis, and patients typically respond to antiarrhythmic agents, particularly <a class="drug drug_general" data-topicid="9359" href="/d/drug information/9359.html" rel="external">adenosine</a>, in a manner similar to patients with RMVT. However, paroxysmal sustained VT is more often symptomatic and less often exercise-provoked than RMVT. (See <a class="local">'Paroxysmal sustained VT'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Idiopathic left ventricular tachycardia (ILVT), also called Belhassen VT or verapamil-responsive VT, is not usually provoked by exercise and, while frequently associated with symptoms of palpitations and presyncope, is rarely associated with syncope of cardiac arrest. ILVT has a right bundle branch block morphology with a left superior frontal plane axis and a relatively narrow QRS duration (typically 0.12 to 0.14 sec). <a class="drug drug_general" data-topicid="10043" href="/d/drug information/10043.html" rel="external">Verapamil</a> is usually effective in the treatment of ILVT, both for the termination of acute episodes and the prevention of recurrence. Additionally, catheter ablation is highly successful in curing ILVT. (See <a class="local">'Idiopathic left ventricular tachycardia'</a> above.)</p><p></p><p class="headingAnchor" id="H3244811063"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Leonard Ganz, MD, FHRS, FACC, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Brooks R, Burgess JH. Idiopathic ventricular tachycardia. A review. Medicine (Baltimore) 1988; 67:271.</a></li><li><a class="nounderline abstract_t">Belhassen B, Viskin S. Idiopathic ventricular tachycardia and fibrillation. J Cardiovasc Electrophysiol 1993; 4:356.</a></li><li><a class="nounderline abstract_t">Tada H, Tadokoro K, Ito S, et al. Idiopathic ventricular arrhythmias originating from the tricuspid annulus: Prevalence, electrocardiographic characteristics, and results of radiofrequency catheter ablation. Heart Rhythm 2007; 4:7.</a></li><li><a class="nounderline abstract_t">FROMENT R, GALLAVARDIN L, CAHEN P. Paroxysmal ventricular tachycardia; a clinical classification. Br Heart J 1953; 15:172.</a></li><li><a class="nounderline abstract_t">Rahilly GT, Prystowsky EN, Zipes DP, et al. Clinical and electrophysiologic findings in patients with repetitive monomorphic ventricular tachycardia and otherwise normal electrocardiogram. Am J Cardiol 1982; 50:459.</a></li><li><a class="nounderline abstract_t">Buxton AE, Waxman HL, Marchlinski FE, et al. Right ventricular tachycardia: clinical and electrophysiologic characteristics. Circulation 1983; 68:917.</a></li><li><a class="nounderline abstract_t">Deal BJ, Miller SM, Scagliotti D, et al. Ventricular tachycardia in a young population without overt heart disease. Circulation 1986; 73:1111.</a></li><li><a class="nounderline abstract_t">Lemery R, Brugada P, Bella PD, et al. Nonischemic ventricular tachycardia. Clinical course and long-term follow-up in patients without clinically overt heart disease. Circulation 1989; 79:990.</a></li><li><a class="nounderline abstract_t">Mont L, Seixas T, Brugada P, et al. The electrocardiographic, clinical, and electrophysiologic spectrum of idiopathic monomorphic ventricular tachycardia. Am Heart J 1992; 124:746.</a></li><li><a class="nounderline abstract_t">Ohe T, Shimomura K, Aihara N, et al. Idiopathic sustained left ventricular tachycardia: clinical and electrophysiologic characteristics. Circulation 1988; 77:560.</a></li><li><a class="nounderline abstract_t">Kinoshita O, Kamakura S, Ohe T, et al. Frequency analysis of signal-averaged electrocardiogram in patients with right ventricular tachycardia. J Am Coll Cardiol 1992; 20:1230.</a></li><li><a class="nounderline abstract_t">Yarlagadda RK, Iwai S, Stein KM, et al. Reversal of cardiomyopathy in patients with repetitive monomorphic ventricular ectopy originating from the right ventricular outflow tract. Circulation 2005; 112:1092.</a></li><li><a class="nounderline abstract_t">Markowitz SM, Litvak BL, Ramirez de Arellano EA, et al. Adenosine-sensitive ventricular tachycardia: right ventricular abnormalities delineated by magnetic resonance imaging. Circulation 1997; 96:1192.</a></li><li><a class="nounderline abstract_t">Globits S, Kreiner G, Frank H, et al. Significance of morphological abnormalities detected by MRI in patients undergoing successful ablation of right ventricular outflow tract tachycardia. Circulation 1997; 96:2633.</a></li><li><a class="nounderline abstract_t">Carlson MD, White RD, Trohman RG, et al. Right ventricular outflow tract ventricular tachycardia: detection of previously unrecognized anatomic abnormalities using cine magnetic resonance imaging. J Am Coll Cardiol 1994; 24:720.</a></li><li><a class="nounderline abstract_t">Eguchi M, Tsuchihashi K, Nakata T, et al. Right ventricular abnormalities assessed by myocardial single-photon emission computed tomography using technetium-99m sestamibi/tetrofosmin in right ventricle-originated ventricular tachyarrhythmias. J Am Coll Cardiol 2000; 36:1767.</a></li><li><a class="nounderline abstract_t">Mehta D, McKenna WJ, Ward DE, et al. Significance of signal-averaged electrocardiography in relation to endomyocardial biopsy and ventricular stimulation studies in patients with ventricular tachycardia without clinically apparent heart disease. J Am Coll Cardiol 1989; 14:372.</a></li><li><a class="nounderline abstract_t">Oakes DF, Manolis AS, Estes NA 3rd. Limited clinical utility of endomyocardial biopsy in patients presenting with ventricular tachycardia without apparent structural heart disease. Clin Cardiol 1992; 15:24.</a></li><li><a class="nounderline abstract_t">Sugrue DD, Holmes DR Jr, Gersh BJ, et al. Cardiac histologic findings in patients with life-threatening ventricular arrhythmias of unknown origin. J Am Coll Cardiol 1984; 4:952.</a></li><li class="breakAll">Fontaine G, Fontaliran F, Lascault G, et al. Arrhythmogenic right ventricular dysplasia. In: Cardiac Electrophysiology: From Cell to Bedside, Zipes DP, Jalife J (Eds), W.B. Saunders, Philadelphia 1995. p.754.</li><li><a class="nounderline abstract_t">Jaoude SA, Leclercq JF, Coumel P. Progressive ECG changes in arrhythmogenic right ventricular disease. Evidence for an evolving disease. Eur Heart J 1996; 17:1717.</a></li><li><a class="nounderline abstract_t">Hoffmayer KS, Machado ON, Marcus GM, et al. Electrocardiographic comparison of ventricular arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract tachycardia. J Am Coll Cardiol 2011; 58:831.</a></li><li><a class="nounderline abstract_t">Niroomand F, Carbucicchio C, Tondo C, et al. Electrophysiological characteristics and outcome in patients with idiopathic right ventricular arrhythmia compared with arrhythmogenic right ventricular dysplasia. Heart 2002; 87:41.</a></li><li><a class="nounderline abstract_t">Boulos M, Lashevsky I, Gepstein L. Usefulness of electroanatomical mapping to differentiate between right ventricular outflow tract tachycardia and arrhythmogenic right ventricular dysplasia. Am J Cardiol 2005; 95:935.</a></li><li><a class="nounderline abstract_t">Corrado D, Basso C, Leoni L, et al. Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia. J Am Coll Cardiol 2008; 51:731.</a></li><li><a class="nounderline abstract_t">Callans DJ, Menz V, Schwartzman D, et al. Repetitive monomorphic tachycardia from the left ventricular outflow tract: electrocardiographic patterns consistent with a left ventricular site of origin. J Am Coll Cardiol 1997; 29:1023.</a></li><li class="breakAll">Coumel P, LeClerq JP, Slama R. monomorphic idiopathic ventricular tachycardia. In: Cardiac Electrophysiology and Arrhythmias, Zipes DP, Jalife J (Eds), Grune and Stratton, Orlando 1985. p.455.</li><li><a class="nounderline abstract_t">Coggins DL, Lee RJ, Sweeney J, et al. Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin. J Am Coll Cardiol 1994; 23:1333.</a></li><li><a class="nounderline abstract_t">Lerman BB, Stein K, Engelstein ED, et al. Mechanism of repetitive monomorphic ventricular tachycardia. Circulation 1995; 92:421.</a></li><li><a class="nounderline abstract_t">Kim RJ, Iwai S, Markowitz SM, et al. Clinical and electrophysiological spectrum of idiopathic ventricular outflow tract arrhythmias. J Am Coll Cardiol 2007; 49:2035.</a></li><li><a class="nounderline abstract_t">Hayashi H, Fujiki A, Tani M, et al. Circadian variation of idiopathic ventricular tachycardia originating from right ventricular outflow tract. Am J Cardiol 1999; 84:99.</a></li><li><a class="nounderline abstract_t">Mitrani RD, Klein LS, Miles WM, et al. Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease. J Am Coll Cardiol 1993; 22:1344.</a></li><li><a class="nounderline abstract_t">Schäfers M, Lerch H, Wichter T, et al. Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardia. J Am Coll Cardiol 1998; 32:181.</a></li><li><a class="nounderline abstract_t">Marchlinski FE, Deely MP, Zado ES. Sex-specific triggers for right ventricular outflow tract tachycardia. Am Heart J 2000; 139:1009.</a></li><li><a class="nounderline abstract_t">Klein LS, Shih HT, Hackett FK, et al. Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease. Circulation 1992; 85:1666.</a></li><li><a class="nounderline abstract_t">Calkins H, Kalbfleisch SJ, el-Atassi R, et al. Relation between efficacy of radiofrequency catheter ablation and site of origin of idiopathic ventricular tachycardia. Am J Cardiol 1993; 71:827.</a></li><li><a class="nounderline abstract_t">Movsowitz C, Schwartzman D, Callans DJ, et al. Idiopathic right ventricular outflow tract tachycardia: narrowing the anatomic location for successful ablation. Am Heart J 1996; 131:930.</a></li><li><a class="nounderline abstract_t">Klein LS, Miles WM. Ablative therapy for ventricular arrhythmias. Prog Cardiovasc Dis 1995; 37:225.</a></li><li><a class="nounderline abstract_t">Jadonath RL, Schwartzman DS, Preminger MW, et al. Utility of the 12-lead electrocardiogram in localizing the origin of right ventricular outflow tract tachycardia. Am Heart J 1995; 130:1107.</a></li><li><a class="nounderline abstract_t">Wilber DJ, Baerman J, Olshansky B, et al. Adenosine-sensitive ventricular tachycardia. Clinical characteristics and response to catheter ablation. Circulation 1993; 87:126.</a></li><li><a class="nounderline abstract_t">Timmermans C, Rodriguez LM, Crijns HJ, et al. Idiopathic left bundle-branch block-shaped ventricular tachycardia may originate above the pulmonary valve. Circulation 2003; 108:1960.</a></li><li><a class="nounderline abstract_t">Sekiguchi Y, Aonuma K, Takahashi A, et al. Electrocardiographic and electrophysiologic characteristics of ventricular tachycardia originating within the pulmonary artery. J Am Coll Cardiol 2005; 45:887.</a></li><li><a class="nounderline abstract_t">Kanagaratnam L, Tomassoni G, Schweikert R, et al. Ventricular tachycardias arising from the aortic sinus of valsalva: an under-recognized variant of left outflow tract ventricular tachycardia. J Am Coll Cardiol 2001; 37:1408.</a></li><li><a class="nounderline abstract_t">Ouyang F, Fotuhi P, Ho SY, et al. Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation. J Am Coll Cardiol 2002; 39:500.</a></li><li><a class="nounderline abstract_t">Frey B, Kreiner G, Fritsch S, et al. Successful treatment of idiopathic left ventricular outflow tract tachycardia by catheter ablation or minimally invasive surgical cryoablation. Pacing Clin Electrophysiol 2000; 23:870.</a></li><li><a class="nounderline abstract_t">Stellbrink C, Diem B, Schauerte P, et al. Transcoronary venous radiofrequency catheter ablation of ventricular tachycardia. J Cardiovasc Electrophysiol 1997; 8:916.</a></li><li><a class="nounderline abstract_t">Tada H, Ito S, Naito S, et al. Idiopathic ventricular arrhythmia arising from the mitral annulus: a distinct subgroup of idiopathic ventricular arrhythmias. J Am Coll Cardiol 2005; 45:877.</a></li><li><a class="nounderline abstract_t">Yamada T, Murakami Y, Yoshida N, et al. Preferential conduction across the ventricular outflow septum in ventricular arrhythmias originating from the aortic sinus cusp. J Am Coll Cardiol 2007; 50:884.</a></li><li><a class="nounderline abstract_t">Yokokawa M, Good E, Desjardins B, et al. Predictors of successful catheter ablation of ventricular arrhythmias arising from the papillary muscles. Heart Rhythm 2010; 7:1654.</a></li><li><a class="nounderline abstract_t">Gill JS, Prasad K, Blaszyk K, et al. Initiating sequences in exercise induced idiopathic ventricular tachycardia of left bundle branch-like morphology. Pacing Clin Electrophysiol 1998; 21:1873.</a></li><li><a class="nounderline abstract_t">Dixit S, Gerstenfeld EP, Callans DJ, Marchlinski FE. Electrocardiographic patterns of superior right ventricular outflow tract tachycardias: distinguishing septal and free-wall sites of origin. J Cardiovasc Electrophysiol 2003; 14:1.</a></li><li><a class="nounderline abstract_t">Callans DJ, Schwartzman D, Gottlieb CD, Marchlinski FE. Insights into the electrophysiology of ventricular tachycardia gained by the catheter ablation experience: "learning while burning". J Cardiovasc Electrophysiol 1994; 5:877.</a></li><li><a class="nounderline abstract_t">Marcus FI, Fontaine GH, Guiraudon G, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation 1982; 65:384.</a></li><li><a class="nounderline abstract_t">Blomström-Lundqvist C, Sabel KG, Olsson SB. A long term follow up of 15 patients with arrhythmogenic right ventricular dysplasia. Br Heart J 1987; 58:477.</a></li><li><a class="nounderline abstract_t">Ritchie AH, Kerr CR, Qi A, Yeung-Lai-Wah JA. Nonsustained ventricular tachycardia arising from the right ventricular outflow tract. Am J Cardiol 1989; 64:594.</a></li><li><a class="nounderline abstract_t">Lerman BB, Belardinelli L, West GA, et al. Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity. Circulation 1986; 74:270.</a></li><li><a class="nounderline abstract_t">Sung RJ, Shapiro WA, Shen EN, et al. Effects of verapamil on ventricular tachycardias possibly caused by reentry, automaticity, and triggered activity. J Clin Invest 1983; 72:350.</a></li><li><a class="nounderline abstract_t">Sung RJ, Keung EC, Nguyen NX, Huycke EC. Effects of beta-adrenergic blockade on verapamil-responsive and verapamil-irresponsive sustained ventricular tachycardias. J Clin Invest 1988; 81:688.</a></li><li><a class="nounderline abstract_t">Farzaneh-Far A, Lerman BB. Idiopathic ventricular outflow tract tachycardia. Heart 2005; 91:136.</a></li><li><a class="nounderline abstract_t">Lerman BB, Dong B, Stein KM, et al. Right ventricular outflow tract tachycardia due to a somatic cell mutation in G protein subunitalphai2. J Clin Invest 1998; 101:2862.</a></li><li><a class="nounderline abstract_t">Viskin S, Rosso R, Rogowski O, Belhassen B. The "short-coupled" variant of right ventricular outflow ventricular tachycardia: a not-so-benign form of benign ventricular tachycardia? J Cardiovasc Electrophysiol 2005; 16:912.</a></li><li><a class="nounderline abstract_t">Noda T, Shimizu W, Taguchi A, et al. Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract. J Am Coll Cardiol 2005; 46:1288.</a></li><li><a class="nounderline abstract_t">Viskin S, Antzelevitch C. The cardiologists' worst nightmare sudden death from "benign" ventricular arrhythmias. J Am Coll Cardiol 2005; 46:1295.</a></li><li><a class="nounderline abstract_t">Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2018; 72:e91.</a></li><li><a class="nounderline abstract_t">Gill JS, Blaszyk K, Ward DE, Camm AJ. Verapamil for the suppression of idiopathic ventricular tachycardia of left bundle branch block-like morphology. Am Heart J 1993; 126:1126.</a></li><li><a class="nounderline abstract_t">Aliot EM, Stevenson WG, Almendral-Garrote JM, et al. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Europace 2009; 11:771.</a></li><li><a class="nounderline abstract_t">Cronin EM, Bogun FM, Maury P, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Heart Rhythm 2020; 17:e2.</a></li><li><a class="nounderline abstract_t">Rodriguez LM, Smeets JL, Timmermans C, Wellens HJ. Predictors for successful ablation of right- and left-sided idiopathic ventricular tachycardia. Am J Cardiol 1997; 79:309.</a></li><li><a class="nounderline abstract_t">Gerstenfeld EP, Dixit S, Callans DJ, et al. Quantitative comparison of spontaneous and paced 12-lead electrocardiogram during right ventricular outflow tract ventricular tachycardia. J Am Coll Cardiol 2003; 41:2046.</a></li><li><a class="nounderline abstract_t">Schweikert RA, Saliba WI, Tomassoni G, et al. Percutaneous pericardial instrumentation for endo-epicardial mapping of previously failed ablations. Circulation 2003; 108:1329.</a></li><li><a class="nounderline abstract_t">Chinushi M, Aizawa Y, Takahashi K, et al. Radiofrequency catheter ablation for idiopathic right ventricular tachycardia with special reference to morphological variation and long-term outcome. Heart 1997; 78:255.</a></li><li><a class="nounderline abstract_t">Flemming MA, Oral H, Kim MH, et al. Electrocardiographic predictors of successful ablation of tachycardia or bigeminy arising in the right ventricular outflow tract. Am J Cardiol 1999; 84:1266.</a></li><li><a class="nounderline abstract_t">Lerman BB, Stein KM, Markowitz SM. Idiopathic right ventricular outflow tract tachycardia: a clinical approach. Pacing Clin Electrophysiol 1996; 19:2120.</a></li><li><a class="nounderline abstract_t">Zipes DP, Foster PR, Troup PJ, Pedersen DH. Atrial induction of ventricular tachycardia: reentry versus triggered automaticity. Am J Cardiol 1979; 44:1.</a></li><li><a class="nounderline abstract_t">Belhassen B, Rotmensch HH, Laniado S. Response of recurrent sustained ventricular tachycardia to verapamil. Br Heart J 1981; 46:679.</a></li><li><a class="nounderline abstract_t">Nakagawa H, Beckman KJ, McClelland JH, et al. Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by a Purkinje potential. Circulation 1993; 88:2607.</a></li><li><a class="nounderline abstract_t">Wen MS, Yeh SJ, Wang CC, et al. Radiofrequency ablation therapy in idiopathic left ventricular tachycardia with no obvious structural heart disease. Circulation 1994; 89:1690.</a></li><li><a class="nounderline abstract_t">German LD, Packer DL, Bardy GH, Gallagher JJ. Ventricular tachycardia induced by atrial stimulation in patients without symptomatic cardiac disease. Am J Cardiol 1983; 52:1202.</a></li><li><a class="nounderline abstract_t">Klein GJ, Millman PJ, Yee R. Recurrent ventricular tachycardia responsive to verapamil. Pacing Clin Electrophysiol 1984; 7:938.</a></li><li><a class="nounderline abstract_t">Ward DE, Nathan AW, Camm AJ. Fascicular tachycardia sensitive to calcium antagonists. Eur Heart J 1984; 5:896.</a></li><li><a class="nounderline abstract_t">Ouyang F, Cappato R, Ernst S, et al. Electroanatomic substrate of idiopathic left ventricular tachycardia: unidirectional block and macroreentry within the purkinje network. Circulation 2002; 105:462.</a></li><li><a class="nounderline abstract_t">Okumura K, Matsuyama K, Miyagi H, et al. Entrainment of idiopathic ventricular tachycardia of left ventricular origin with evidence for reentry with an area of slow conduction and effect of verapamil. Am J Cardiol 1988; 62:727.</a></li><li><a class="nounderline abstract_t">Kinoshita O, Kamakura S, Ohe T, et al. Spectral analysis of signal-averaged electrocardiograms in patients with idiopathic ventricular tachycardia of left ventricular origin. Circulation 1992; 85:2054.</a></li><li><a class="nounderline abstract_t">Nogami A, Naito S, Tada H, et al. Demonstration of diastolic and presystolic Purkinje potentials as critical potentials in a macroreentry circuit of verapamil-sensitive idiopathic left ventricular tachycardia. J Am Coll Cardiol 2000; 36:811.</a></li><li><a class="nounderline abstract_t">Nogami A, Naito S, Tada H, et al. Verapamil-sensitive left anterior fascicular ventricular tachycardia: results of radiofrequency ablation in six patients. J Cardiovasc Electrophysiol 1998; 9:1269.</a></li><li><a class="nounderline abstract_t">Francis J, Venugopal K, Khadar SA, et al. Idiopathic fascicular ventricular tachycardia. Indian Pacing Electrophysiol J 2004; 4:98.</a></li><li><a class="nounderline abstract_t">Gupta AK, Kumar AV, Lokhandwala YY, et al. Primary radiofrequency ablation for incessant idiopathic ventricular tachycardia. Pacing Clin Electrophysiol 2002; 25:1555.</a></li><li><a class="nounderline abstract_t">Eisenberg SJ, Scheinman MM, Dullet NK, et al. Sudden cardiac death and polymorphous ventricular tachycardia in patients with normal QT intervals and normal systolic cardiac function. Am J Cardiol 1995; 75:687.</a></li><li><a class="nounderline abstract_t">Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002; 106:69.</a></li><li><a class="nounderline abstract_t">Wilde AA, Bhuiyan ZA, Crotti L, et al. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med 2008; 358:2024.</a></li><li><a class="nounderline abstract_t">Tan JH, Scheinman MM. Exercise-induced polymorphic ventricular tachycardia in adults without structural heart disease. Am J Cardiol 2008; 101:1142.</a></li><li><a class="nounderline abstract_t">Meissner MD, Lehmann MH, Steinman RT, et al. Ventricular fibrillation in patients without significant structural heart disease: a multicenter experience with implantable cardioverter-defibrillator therapy. J Am Coll Cardiol 1993; 21:1406.</a></li></ol></div><div id="topicVersionRevision">Topic 965 Version 33.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3045477" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Idiopathic ventricular tachycardia. A review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8269305" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Idiopathic ventricular tachycardia and fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17198982" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Idiopathic ventricular arrhythmias originating from the tricuspid annulus: Prevalence, electrocardiographic characteristics, and results of radiofrequency catheter ablation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13041996" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Paroxysmal ventricular tachycardia; a clinical classification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6810685" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Clinical and electrophysiologic findings in patients with repetitive monomorphic ventricular tachycardia and otherwise normal electrocardiogram.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6137291" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Right ventricular tachycardia: clinical and electrophysiologic characteristics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3698245" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Ventricular tachycardia in a young population without overt heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2713978" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Nonischemic ventricular tachycardia. Clinical course and long-term follow-up in patients without clinically overt heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1514503" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The electrocardiographic, clinical, and electrophysiologic spectrum of idiopathic monomorphic ventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3342487" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Idiopathic sustained left ventricular tachycardia: clinical and electrophysiologic characteristics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1401626" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Frequency analysis of signal-averaged electrocardiogram in patients with right ventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16103234" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Reversal of cardiomyopathy in patients with repetitive monomorphic ventricular ectopy originating from the right ventricular outflow tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9286949" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Adenosine-sensitive ventricular tachycardia: right ventricular abnormalities delineated by magnetic resonance imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9355904" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Significance of morphological abnormalities detected by MRI in patients undergoing successful ablation of right ventricular outflow tract tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8077544" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Right ventricular outflow tract ventricular tachycardia: detection of previously unrecognized anatomic abnormalities using cine magnetic resonance imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11092642" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Right ventricular abnormalities assessed by myocardial single-photon emission computed tomography using technetium-99m sestamibi/tetrofosmin in right ventricle-originated ventricular tachyarrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2754126" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Significance of signal-averaged electrocardiography in relation to endomyocardial biopsy and ventricular stimulation studies in patients with ventricular tachycardia without clinically apparent heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1541071" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Limited clinical utility of endomyocardial biopsy in patients presenting with ventricular tachycardia without apparent structural heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6491087" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Cardiac histologic findings in patients with life-threatening ventricular arrhythmias of unknown origin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6491087" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Cardiac histologic findings in patients with life-threatening ventricular arrhythmias of unknown origin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8922921" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Progressive ECG changes in arrhythmogenic right ventricular disease. Evidence for an evolving disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21835319" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Electrocardiographic comparison of ventricular arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11751663" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Electrophysiological characteristics and outcome in patients with idiopathic right ventricular arrhythmia compared with arrhythmogenic right ventricular dysplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15820158" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Usefulness of electroanatomical mapping to differentiate between right ventricular outflow tract tachycardia and arrhythmogenic right ventricular dysplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18279737" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9120154" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Repetitive monomorphic tachycardia from the left ventricular outflow tract: electrocardiographic patterns consistent with a left ventricular site of origin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9120154" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Repetitive monomorphic tachycardia from the left ventricular outflow tract: electrocardiographic patterns consistent with a left ventricular site of origin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8176091" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7634458" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Mechanism of repetitive monomorphic ventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17512360" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Clinical and electrophysiological spectrum of idiopathic ventricular outflow tract arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10404862" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Circadian variation of idiopathic ventricular tachycardia originating from right ventricular outflow tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8227790" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9669268" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10827381" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Sex-specific triggers for right ventricular outflow tract tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1572025" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8456762" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Relation between efficacy of radiofrequency catheter ablation and site of origin of idiopathic ventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8615312" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Idiopathic right ventricular outflow tract tachycardia: narrowing the anatomic location for successful ablation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7831468" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Ablative therapy for ventricular arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7484743" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Utility of the 12-lead electrocardiogram in localizing the origin of right ventricular outflow tract tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8418999" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Adenosine-sensitive ventricular tachycardia. Clinical characteristics and response to catheter ablation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14530199" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Idiopathic left bundle-branch block-shaped ventricular tachycardia may originate above the pulmonary valve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15766825" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Electrocardiographic and electrophysiologic characteristics of ventricular tachycardia originating within the pulmonary artery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11300454" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Ventricular tachycardias arising from the aortic sinus of valsalva: an under-recognized variant of left outflow tract ventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11823089" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10833708" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Successful treatment of idiopathic left ventricular outflow tract tachycardia by catheter ablation or minimally invasive surgical cryoablation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9261718" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Transcoronary venous radiofrequency catheter ablation of ventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15766824" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Idiopathic ventricular arrhythmia arising from the mitral annulus: a distinct subgroup of idiopathic ventricular arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17719476" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Preferential conduction across the ventricular outflow septum in ventricular arrhythmias originating from the aortic sinus cusp.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20637311" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Predictors of successful catheter ablation of ventricular arrhythmias arising from the papillary muscles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9793082" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Initiating sequences in exercise induced idiopathic ventricular tachycardia of left bundle branch-like morphology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12625602" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Electrocardiographic patterns of superior right ventricular outflow tract tachycardias: distinguishing septal and free-wall sites of origin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7874333" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Insights into the electrophysiology of ventricular tachycardia gained by the catheter ablation experience: "learning while burning".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7053899" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Right ventricular dysplasia: a report of 24 adult cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3676037" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : A long term follow up of 15 patients with arrhythmogenic right ventricular dysplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2571287" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Nonsustained ventricular tachycardia arising from the right ventricular outflow tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3015453" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6874951" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Effects of verapamil on ventricular tachycardias possibly caused by reentry, automaticity, and triggered activity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2893808" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Effects of beta-adrenergic blockade on verapamil-responsive and verapamil-irresponsive sustained ventricular tachycardias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15657214" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Idiopathic ventricular outflow tract tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9637720" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Right ventricular outflow tract tachycardia due to a somatic cell mutation in G protein subunitalphai2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16101636" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : The "short-coupled" variant of right ventricular outflow ventricular tachycardia: a not-so-benign form of benign ventricular tachycardia?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16198845" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16198846" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : The cardiologists' worst nightmare sudden death from "benign" ventricular arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29097296" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8237755" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Verapamil for the suppression of idiopathic ventricular tachycardia of left bundle branch block-like morphology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19443434" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31085023" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9036750" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Predictors for successful ablation of right- and left-sided idiopathic ventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12798580" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Quantitative comparison of spontaneous and paced 12-lead electrocardiogram during right ventricular outflow tract ventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12952851" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Percutaneous pericardial instrumentation for endo-epicardial mapping of previously failed ablations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9391287" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Radiofrequency catheter ablation for idiopathic right ventricular tachycardia with special reference to morphological variation and long-term outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10569344" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Electrocardiographic predictors of successful ablation of tachycardia or bigeminy arising in the right ventricular outflow tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8994952" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Idiopathic right ventricular outflow tract tachycardia: a clinical approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/453035" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Atrial induction of ventricular tachycardia: reentry versus triggered automaticity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7317238" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Response of recurrent sustained ventricular tachycardia to verapamil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8252671" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by a Purkinje potential.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8149535" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Radiofrequency ablation therapy in idiopathic left ventricular tachycardia with no obvious structural heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6650408" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Ventricular tachycardia induced by atrial stimulation in patients without symptomatic cardiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6209631" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Recurrent ventricular tachycardia responsive to verapamil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6529940" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Fascicular tachycardia sensitive to calcium antagonists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11815429" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Electroanatomic substrate of idiopathic left ventricular tachycardia: unidirectional block and macroreentry within the purkinje network.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3421173" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Entrainment of idiopathic ventricular tachycardia of left ventricular origin with evidence for reentry with an area of slow conduction and effect of verapamil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1591823" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Spectral analysis of signal-averaged electrocardiograms in patients with idiopathic ventricular tachycardia of left ventricular origin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10987604" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Demonstration of diastolic and presystolic Purkinje potentials as critical potentials in a macroreentry circuit of verapamil-sensitive idiopathic left ventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9869526" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Verapamil-sensitive left anterior fascicular ventricular tachycardia: results of radiofrequency ablation in six patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16943977" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Idiopathic fascicular ventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12494611" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Primary radiofrequency ablation for incessant idiopathic ventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7900661" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Sudden cardiac death and polymorphous ventricular tachycardia in patients with normal QT intervals and normal systolic cardiac function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12093772" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18463378" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18394448" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Exercise-induced polymorphic ventricular tachycardia in adults without structural heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8473649" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Ventricular fibrillation in patients without significant structural heart disease: a multicenter experience with implantable cardioverter-defibrillator therapy.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
